Great Tree Pharmacy Co., Ltd.
TPEX:6469 Rapporto sulle azioni
Cap. di mercato: NT$23.3b
Aggiungi alla lista di controlloGreat Tree Pharmacy Performance dei guadagni passati
Il passato criteri di controllo 3/6 Great Tree Pharmacy ha registrato una crescita degli utili a un tasso medio annuo di 31.9%, mentre il settore Consumer Retailing ha registrato utili in crescita a un tasso medio annuo di 0.4%. I ricavi sono stati in crescita a un tasso medio annuo di 20%. Il ritorno sul capitale proprio di Great Tree Pharmacy è 20.1% e ha margini netti di 4%.
Informazioni chiave
31.9%
Tasso di crescita degli utili
30.2%
Tasso di crescita dell'EPS
Consumer Retailing Crescita del settore 0.05% Tasso di crescita dei ricavi 20.0% Rendimento del capitale proprio 20.1% Margine netto 4.0% Ultimo aggiornamento sui guadagni 30 Sep 2024
Aggiornamenti sulle prestazioni recenti
Third quarter 2024 earnings released: EPS: NT$1.27 (vs NT$1.26 in 3Q 2023) Nov 11
Second quarter 2024 earnings released: EPS: NT$1.29 (vs NT$1.29 in 2Q 2023) Aug 13
Great Tree Pharmacy Co., Ltd. to Report Q2, 2024 Results on Aug 09, 2024 Aug 02
First quarter 2024 earnings: EPS and revenues miss analyst expectations May 18 Great Tree Pharmacy Co., Ltd. to Report Q1, 2024 Results on May 10, 2024 May 03
Full year 2023 earnings: EPS and revenues miss analyst expectations Mar 06
Mostra tutti gli aggiornamenti
Third quarter 2024 earnings released: EPS: NT$1.27 (vs NT$1.26 in 3Q 2023) Nov 11
New minor risk - Shareholder dilution Aug 21
Second quarter 2024 earnings released: EPS: NT$1.29 (vs NT$1.29 in 2Q 2023) Aug 13
Great Tree Pharmacy Co., Ltd. to Report Q2, 2024 Results on Aug 09, 2024 Aug 02
Upcoming dividend of NT$3.60 per share Jul 03
Dividend of NT$3.60 announced Jun 13
Great Tree Pharmacy Co., Ltd. Announces Cash Dividend , Payable on July 31, 2024 Jun 13
First quarter 2024 earnings: EPS and revenues miss analyst expectations May 18
Consensus EPS estimates fall by 13% May 14 Great Tree Pharmacy Co., Ltd. to Report Q1, 2024 Results on May 10, 2024 May 03
Less than half of directors are independent Apr 03
Full year 2023 earnings: EPS and revenues miss analyst expectations Mar 06 Great Tree Pharmacy Co., Ltd. announced a financing transaction
New minor risk - Shareholder dilution Dec 23
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Nov 15
New major risk - Earnings quality Aug 12
Great Tree Pharmacy Co., Ltd. Announces Convener of Audit Committee Changes Aug 11
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Aug 11
Consensus EPS estimates fall by 18% Aug 11
Upcoming dividend of NT$4.70 per share at 1.3% yield Jun 28
First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Jun 07
Great Tree Pharmacy Co., Ltd. Announces Cash Dividend for the Year 2022, Payable on July 28, 2023 Jun 06
Great Tree Pharmacy Co., Ltd. Appoints Min-Hsiung Pan as Member of the Audit Committee and the Remuneration Committee Jun 02
Great Tree Pharmacy Co., Ltd. Elects Min-Hsiung Pan as Independent Director Jun 01
Now 23% undervalued May 12
Full year 2022 earnings: EPS misses analyst expectations Mar 01
Price target increased by 7.6% to NT$324 Feb 24
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Nov 16
Less than half of directors are independent Nov 16
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Nov 13
Now 20% undervalued Oct 26 Great Tree Pharmacy Co., Ltd. announced that it has received TWD 220 million in funding from Sugi Holdings Co.,Ltd. Sep 17
Great Tree Pharmacy Co., Ltd. announced that it expects to receive funding from Sugi Holdings Co.,Ltd. Sep 08
Consensus forecasts updated Aug 30
Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Aug 13
Investor sentiment improved over the past week Jul 11
Upcoming dividend of NT$2.57 per share Jun 22
Great Tree Pharmacy Co., Ltd. Announces Cash Dividend, Payable on July 21, 2022 Jun 15
Investor sentiment improved over the past week Jun 10
Less than half of directors are independent May 16
First quarter 2022 earnings released: EPS: NT$1.67 (vs NT$1.04 in 1Q 2021) May 14
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Feb 28
Great Tree Pharmacy Co., Ltd. Approves Dividend Distribution for the Year Ended December 31, 2021 Feb 27
Great Tree Pharmacy Co., Ltd., Annual General Meeting, May 31, 2022 Feb 26
Investor sentiment improved over the past week Feb 24
Third quarter 2021 earnings released: EPS NT$1.51 (vs NT$0.66 in 3Q 2020) Nov 12
Investor sentiment deteriorated over the past week Sep 10
Investor sentiment improved over the past week Aug 24
Second quarter 2021 earnings released: EPS NT$2.20 (vs NT$0.86 in 2Q 2020) Aug 13
Investor sentiment improved over the past week Jul 23
Upcoming dividend of NT$0.99 per share Jul 15
Investor sentiment improved over the past week Jun 24
First quarter 2021 earnings released: EPS NT$1.34 (vs NT$0.92 in 1Q 2020) May 15
Investor sentiment improved over the past week Mar 24
There Are Reasons To Feel Uneasy About Great Tree Pharmacy's (GTSM:6469) Returns On Capital Mar 24
Great Tree Pharmacy Co., Ltd. Approves Dividend Distribution Mar 20
Great Tree Pharmacy Co., Ltd., Annual General Meeting, Jun 24, 2021 Mar 19
Full year 2020 earnings released: EPS NT$3.73 (vs NT$2.77 in FY 2019) Mar 19
New 90-day high: NT$101 Mar 12
Is Great Tree Pharmacy (GTSM:6469) A Risky Investment? Mar 03
Is Great Tree Pharmacy Co., Ltd.'s (GTSM:6469) Stock's Recent Performance A Reflection Of Its Financial Health? Feb 09
Great Tree Pharmacy's (GTSM:6469) Earnings Are Growing But Is There More To The Story? Jan 19
Did You Miss Great Tree Pharmacy's (GTSM:6469) 71% Share Price Gain? Dec 28
Should We Be Excited About The Trends Of Returns At Great Tree Pharmacy (GTSM:6469)? Dec 09
New 90-day high: NT$100.00 Nov 24
Third quarter 2020 earnings released: EPS NT$0.86 Nov 12
New 90-day high - NT$94.50 Aug 24
First half earnings released Aug 13
Ripartizione dei ricavi e delle spese
Come Great Tree Pharmacy guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate TPEX:6469 Ricavi, spese e utili (TWD Millions ) Data Ricavi Guadagni Spese G+A Spese di R&S 30 Sep 24 16,974 685 3,938 0 30 Jun 24 16,690 681 3,836 0 31 Mar 24 16,536 678 3,779 0 31 Dec 23 16,144 666 3,680 0 30 Sep 23 15,735 655 3,577 0 30 Jun 23 15,294 661 3,431 0 31 Mar 23 15,185 739 3,308 0 31 Dec 22 14,565 700 3,149 0 30 Sep 22 13,827 644 2,922 0 30 Jun 22 13,124 580 2,781 0 31 Mar 22 11,993 454 2,587 0 31 Dec 21 11,281 407 2,451 0 30 Sep 21 10,617 354 2,338 0 30 Jun 21 9,954 295 2,214 0 31 Mar 21 9,108 220 2,082 0 31 Dec 20 8,641 194 1,959 0 30 Sep 20 8,079 171 1,849 0 30 Jun 20 7,540 163 1,714 0 31 Mar 20 7,137 156 1,578 0 31 Dec 19 6,602 136 1,453 0 30 Sep 19 6,170 134 1,320 0 30 Jun 19 5,727 124 1,233 0 31 Mar 19 5,296 109 1,156 0 31 Dec 18 4,901 106 1,081 0 30 Sep 18 4,503 104 1,011 0 30 Jun 18 4,173 107 933 0 31 Mar 18 3,889 107 874 0 31 Dec 17 3,624 102 812 0 30 Sep 17 3,420 96 754 0 30 Jun 17 3,192 92 692 0 31 Mar 17 2,983 90 627 0 31 Dec 16 2,802 93 578 0 30 Sep 16 2,615 101 536 0 30 Jun 16 2,465 94 506 0 31 Mar 16 2,317 91 481 0 31 Dec 15 2,160 77 459 0 30 Sep 15 2,047 83 453 0 30 Jun 15 1,919 79 440 0 31 Mar 15 1,774 82 420 0 31 Dec 14 1,662 96 396 0 30 Sep 14 1,473 75 352 0 30 Jun 14 1,349 80 324 0 31 Mar 14 1,242 74 289 0 31 Dec 13 1,136 68 255 0
Guadagni di qualità: 6469 ha guadagni di alta qualità .
Margine di profitto in crescita: Gli attuali margini di profitto netti di 6469 (4%) sono inferiori rispetto allo scorso anno (4.2%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: Gli utili di 6469 sono cresciuti in modo significativo del 31.9% all'anno negli ultimi 5 anni.
Accelerare la crescita: La crescita degli utili di 6469 nell'ultimo anno ( 4.5% ) è inferiore alla media quinquennale ( 31.9% all'anno).
Guadagni vs Settore: La crescita degli utili 6469 nell'ultimo anno ( 4.5% ) non ha superato quella del settore Consumer Retailing 7.9%.
Rendimento del capitale proprio
ROE elevato: Il Return on Equity ( 20.1% ) di 6469 è considerato alto .
Rendimento delle attività
Rendimento del capitale investito
Scoprire le aziende con forti performance passate Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}